USCAST 2023 Virtual Public Meeting
Piperacillin/Tazobactam Breakpoints: Enterobacterales and P. aeruginosa
Thomas Lodise, Pharm. D.
Executive Committee, USCAST
Re-Evaluation of Aminoglycoside
In Vitro Susceptibility Test Criteria
Sujata Bhavnani, Pharm. D.
Vice Chair, USCAST
2019 USCAST Annual Public Meeting
Susceptibility Breakpoints: The Peril of Using the ECOFF
Sujata M. Bhavnani, Pharm.D., M.S.
DOWNLOAD SLIDES
Machine Learning and AI: The End of Susceptibility Breakpoints?
DOWNLOAD SLIDES
Old Antibiotic Breakpoint Reevaluations: An Urgent Unmet Medical Need
Paul G. Ambrose, Pharm. D.
DOWNLOAD SLIDES
2018 USCAST Annual Public Meeting
Beta-lactamase Inhibitor PK/PD and Breakpoint Considerations
Paul G. Ambrose, Pharm. D.
DOWNLOAD SLIDES
Antimicrobial Stewardship Challenges Posed by Suboptimal Breakpoints
Jason M. Pogue, Pharm. D.
DOWNLOAD SLIDES
Aminoglycosides: Re-Evaluation of PK-PD Target Attainment and Breakpoints
Sujata M. Bhavnani, Pharm. D., M.S.
DOWNLOAD SLIDES
2017 USCAST Annual Public Meeting
Polymyxin (colistin and polymyxin B) Breakpoints
Jason M. Pogue, Pharm. D.
Michael N. Dudley, Pharm. D.
Keith A. Rodvold, Pharm. D.
DOWNLOAD SLIDES
Tetracycline Breakpoint Harmonization Project: Preparation for New Drugs in an Old Class
Ronald N. Jones, MD
David R. Andes, MD
DOWNLOAD SLIDES